Differential expression of DNA repair genes in Hispanic women with breast cancer.

作者: Jaime Matta , Luisa Morales , Manuel Bayona , Julie Dutil , Carolina Alvarez

DOI: 10.9777/MCB.2013.10006

关键词:

摘要: Previous studies have found a link between low DNA repair capacity (DRC) level and increased risk for breast cancer (BC). A recent study by Matta et al. 2012 showed that women with BC an average reduction of 60% in DRC compared to controls (P < 0.001). Using the same group Hispanic women, we selected subgroup cases (n=35) (n=2) who donated their tumors normal tissue performing molecular order 1) compare expression genes without this disease, 2) assess correlation gene levels, 3) examine whether levels are associated tumor profiling when were stratified according hormone receptor status. measured lymphocytes means host-cell reactivation assay. Gene microarray analysis. Twenty-one be differentially significantly expressed BC. Those candidate CHEK2, EME1 (MMS4L), ERCC3 (XPB), FANCM, H2AFX (H2AX), HMGB1, HUS1, MBD4, NEIL3, PCNA, RAD1, RAD23B, RAD51, RAD54B, RDM1 (RAD52B), SHFM1 (DSS1), TP1, UBE2N (UBC13) XRCC5 (Ku80). Most (n=18 or 82%) overexpressed, ranging from 3.76-fold (RDM1) 1.47-fold (XRCC5). Only 4 (18%) underexpressed, 62% (SAPCD1) 25% (RAD23B). Statistically significant positive correlations FANCB FANCA genes. We discuss clinical translational significance these findings. Our results support usefulness studying as measure risk. This also provides list might dysregulation cancer.

参考文章(60)
Balvinder Shoker, Racial differences in breast carcinoma Breast Cancer Research. ,vol. 2, pp. 66650- ,(2000) , 10.1186/BCR-2000-66650
Emmanuele Crespan, Alessandra Amoroso, Giovanni Maga, DNA polymerases and mutagenesis in human cancers. Sub-cellular biochemistry. ,vol. 50, pp. 165- 188 ,(2010) , 10.1007/978-90-481-3471-7_9
Genevieve M. Matanoski, William F. Athas, Mohammad A. Hedayati, Lawrence Grossman, Evan R. Farmer, Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Research. ,vol. 51, pp. 5786- 5793 ,(1991)
Julyann Pérez-Mayoral, Alba L. Pacheco-Torres, Luisa Morales, Heidi Acosta-Rodríguez, Jaime L. Matta, Julie Dutil, Genetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican women Molecular Carcinogenesis. ,vol. 52, pp. 127- 138 ,(2013) , 10.1002/MC.22056
L Kadouri, Z Kote-Jarai, A Hubert, F Durocher, D Abeliovich, B Glaser, T Hamburger, R A Eeles, T Peretz, A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers British Journal of Cancer. ,vol. 90, pp. 2002- 2005 ,(2004) , 10.1038/SJ.BJC.6601837
Thomas Helleday, Eva Petermann, Cecilia Lundin, Ben Hodgson, Ricky A. Sharma, DNA repair pathways as targets for cancer therapy Nature Reviews Cancer. ,vol. 8, pp. 193- 204 ,(2008) , 10.1038/NRC2342
Hiroaki Murata, Nada H Khattar, Yuna Kang, Liya Gu, Guo-Min Li, Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability. Oncogene. ,vol. 21, pp. 5696- 5703 ,(2002) , 10.1038/SJ.ONC.1205683
Edward G. Mansour, Peter M. Ravdin, Lynn Dressier, Prognostic factors in early breast carcinoma Cancer. ,vol. 74, pp. 381- 400 ,(1994) , 10.1002/CNCR.2820741326
Janusz Blasiak, Karolina Przybyłowska, Agnieszka Czechowska, Marek Zadrozny, Tomasz Pertyński, Jan Rykała, Agnieszka Kołacińska, Zbigniew Morawiec, Józef Drzewoski, Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer. Acta Biochimica Polonica. ,vol. 50, pp. 249- 253 ,(2003) , 10.18388/ABP.2003_3733
Genevieve M. Monsees, Peter Kraft, Stephen J. Chanock, David J. Hunter, Jiali Han, Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk Breast Cancer Research and Treatment. ,vol. 125, pp. 207- 214 ,(2011) , 10.1007/S10549-010-0947-3